News

510(k) predictions, a new Blue Cross Blue Shield spinoff (Weekend Rounds)

Among the life science current events from last week: a Blue Cross Blue Shield spinoff, predictions on the changes in 510(k) regulations, Cleveland Clinic increases its interest in personalized medicine, and Cleveland’s medical mart unveils its early tenants.

A review of life science current events reported by MedCity News this week:

Health insurance company BCBS to spin out Blue Health Intelligence. Blue Cross and Blue Shield Association will provide Blue Health Intelligence’s services to a larger pool of stakeholders and access larger and more vast revenue opportunities.

Medtronic’s Hawkins: 510(k) changes to be ‘neutral to slightly negative.’ Medtronic’s Bill Hawkins told attendees at the JP Morgan Healthcare Conference that updates to 510(k) “will be neutral to slightly negative” for those trying to create new innovative medical devices.

Cleveland Clinic to open personalized medicine center. It’s no secret why anyone in the healthcare industry would want to move into personalized medicine — the field is expected to attract more and more dollars in the future. The worldwide pharmaceutical, medical device and diagnostics segment of the market is $24 billion and growing at 10 percent a year.

Cleveland medical mart’s tenants: Big numbers, few big names (so far). From hospitals to device manufacturers to health IT companies to furniture makers, the list of the Cleveland medical mart’s first announced tenants is impressive in breadth. But the lack of many big-name, high-profile national healthcare leaders makes the list seem, at first glance, underwhelming. Think again, says MMPI.